| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/01/2003 | US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides |
| 05/01/2003 | US20030083272 Sense mrna therapy |
| 05/01/2003 | US20030083265 TGF-beta inhibitors and methods |
| 05/01/2003 | US20030083254 Heparanase-like proteins and nucleotides that encode them |
| 05/01/2003 | US20030083252 Neuronal uses of BMP-11 |
| 05/01/2003 | US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule |
| 05/01/2003 | US20030083242 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/01/2003 | US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation |
| 05/01/2003 | US20030082786 PEG-modified uricase |
| 05/01/2003 | US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same |
| 05/01/2003 | US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 05/01/2003 | US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders |
| 05/01/2003 | US20030082230 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 05/01/2003 | US20030082207 Method of using HIV protease inhibiting compounds |
| 05/01/2003 | US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases |
| 05/01/2003 | US20030082184 Uses of mammalian cytokine; related reagents |
| 05/01/2003 | US20030082180 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament |
| 05/01/2003 | US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 05/01/2003 | CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2464271A1 Integrin targeting compounds |
| 05/01/2003 | CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 05/01/2003 | CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative |
| 05/01/2003 | CA2463311A1 Androgen receptor modulators and methods of use thereof |
| 05/01/2003 | CA2463101A1 Azole derivatives and pharmaceutical compositions containing them |
| 05/01/2003 | CA2460680A1 Substituted indazole compounds for the treatment of inflammation |
| 05/01/2003 | CA2458958A1 Method and apparatus for dispensing inhalator medicament |
| 04/30/2003 | CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin |
| 04/30/2003 | CN1414961A Substituted oximes and hydrazones as neurokinin antagonists |
| 04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
| 04/30/2003 | CN1414864A Adhesive particle DNA constructs and method of making and using the same |
| 04/30/2003 | CN1414854A Phosphonate compounds |
| 04/30/2003 | CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method |
| 04/30/2003 | CN1413721A Chinese drugs for treating osteoporosis of lumbar vertebra |
| 04/30/2003 | CN1413719A Drug for treating ischemic necrosis of femoral head |
| 04/30/2003 | CN1413714A Drug for treating gout and method for preparing pill thereof |
| 04/30/2003 | CN1413702A 金乌骨通胶囊及其制备工艺 Ukrainian bone Capsule and its preparation process |
| 04/30/2003 | CN1413700A Drug for treating rheumatism |
| 04/30/2003 | CN1413680A Chinese medicine for treating hyperosteogeny |
| 04/30/2003 | CN1413671A Capsule for treating arthralgia aggravated by cold and preparation method |
| 04/30/2003 | CN1413668A Chinese medine for trauma and preparation method |
| 04/30/2003 | CN1413664A Chinese medicine for treating gout |
| 04/30/2003 | CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof |
| 04/30/2003 | CN1413639A Chinese medicine composition for treating prolapse of lumbar intervertebral disc and sciatica |
| 04/30/2003 | CN1413638A Chinese medicine composite for treating gouty arthropathy |
| 04/30/2003 | CN1413637A Chinese medicine composite for treating rheumatism, rheumatic arthritis |
| 04/30/2003 | CN1413635A Quick-acting rheumatic arthritis adhesive plaster and its preparation technology |
| 04/30/2003 | CN1413634A Hyperosteogeny adhesive plaster and its preparation technology |
| 04/30/2003 | CN1413628A External used medicine for treating external wound and its production method and application |
| 04/30/2003 | CN1413621A Trachelology recovery powder combined with goose egg |
| 04/30/2003 | CN1413614A Yubi pill-for treatment of rheumatism and atrophic arthritis and its preparation method |
| 04/30/2003 | CN1413604A Method for preparing medicine for treatment of arthralgia-syndrome pain disease |
| 04/30/2003 | CN1413603A Chinese Patent drug for treatment of prolaps of lumbar intervertebral disc |
| 04/30/2003 | CN1413599A Capsule for removing obstruction inchannels to removing blood stasis and its making method |
| 04/30/2003 | CN1107072C Programing cell death induced molecule II |
| 04/30/2003 | CN1107058C Subsitituted isoxazoles for treatment of inflammation |
| 04/30/2003 | CN1106857C Preparation for treating soft tissue contusion |
| 04/30/2003 | CN1106848C Medicine for treating lumbar vertebrae disease and its preparation process |
| 04/29/2003 | US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/29/2003 | US6555535 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors |
| 04/29/2003 | US6555527 Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng |
| 04/29/2003 | US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/24/2003 | WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033677A2 Dimerized growth factor and materials and methods for producing it |
| 04/24/2003 | WO2003033664A2 Bone anti-resorptive compounds |
| 04/24/2003 | WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/24/2003 | WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | WO2003033526A2 Synthesis of cyclosporin analogs |
| 04/24/2003 | WO2003033508A1 Pharmaceutically acceptable alendronate salts in amorphous form |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033501A1 Himbacine analogues as thrombin receptor antagonists |
| 04/24/2003 | WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/24/2003 | WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor |
| 04/24/2003 | WO2003033470A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033003A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032993A1 Use of phosphorodiesterase iv inhibitors |
| 04/24/2003 | WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |